203 related articles for article (PubMed ID: 15333583)
1. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
Bruno IG; Jin W; Cote GJ
Hum Mol Genet; 2004 Oct; 13(20):2409-20. PubMed ID: 15333583
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma cell-specific expression of fibroblast growth factor receptor-1beta requires an intronic repressor of RNA splicing.
Jin W; Bi W; Huang ES; Cote GJ
Cancer Res; 1999 Jan; 59(2):316-9. PubMed ID: 9927039
[TBL] [Abstract][Full Text] [Related]
3. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
4. Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion.
Jin W; Bruno IG; Xie TX; Sanger LJ; Cote GJ
Cancer Res; 2003 Oct; 63(19):6154-7. PubMed ID: 14559795
[TBL] [Abstract][Full Text] [Related]
5. Enhancer-dependent splicing of FGFR1 alpha-exon is repressed by RNA interference-mediated down-regulation of SRp55.
Jin W; Cote GJ
Cancer Res; 2004 Dec; 64(24):8901-5. PubMed ID: 15604250
[TBL] [Abstract][Full Text] [Related]
6. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein.
Carstens RP; Wagner EJ; Garcia-Blanco MA
Mol Cell Biol; 2000 Oct; 20(19):7388-400. PubMed ID: 10982855
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of fibronectin mRNAs in chondrosarcoma cells: role of far upstream intron sequences.
Flanagan M; Liang H; Norton PA
J Cell Biochem; 2003 Nov; 90(4):709-18. PubMed ID: 14587027
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.
Jin W; McCutcheon IE; Fuller GN; Huang ES; Cote GJ
Cancer Res; 2000 Mar; 60(5):1221-4. PubMed ID: 10728679
[TBL] [Abstract][Full Text] [Related]
9. A unique intronic splicing enhancer controls the inclusion of the agrin Y exon.
Wei N; Lin CQ; Modafferi EF; Gomes WA; Black DL
RNA; 1997 Nov; 3(11):1275-88. PubMed ID: 9409619
[TBL] [Abstract][Full Text] [Related]
10. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
[TBL] [Abstract][Full Text] [Related]
11. Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells.
Jin W; Huang ES; Bi W; Cote GJ
J Biol Chem; 1999 Sep; 274(39):28035-41. PubMed ID: 10488155
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of fibroblast growth factor receptor 1 expression in human glioblastoma cell contributes to the cell growth suppression].
Yamada SM; Yamaguchi F; Morrison RS; Takahashi H; Teramoto A
No To Shinkei; 1998 Dec; 50(12):1101-5. PubMed ID: 9989355
[TBL] [Abstract][Full Text] [Related]
13. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer.
Jang JH; Shin KH; Park YJ; Lee RJ; McKeehan WL; Park JG
Cancer Res; 2000 Aug; 60(15):4049-52. PubMed ID: 10945607
[TBL] [Abstract][Full Text] [Related]
14. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
15. An intron with a constitutive transport element is retained in a Tap messenger RNA.
Li Y; Bor YC; Misawa Y; Xue Y; Rekosh D; Hammarskjöld ML
Nature; 2006 Sep; 443(7108):234-7. PubMed ID: 16971948
[TBL] [Abstract][Full Text] [Related]
16. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
17. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
Errington SJ; Mann CJ; Fletcher S; Wilton SD
J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
[TBL] [Abstract][Full Text] [Related]
18. Intronic UGG repeats coordinate splicing of CD44 alternative exons v8 and v9.
Galiana-Arnoux D; Del Gatto-Konczak F; Gesnel MC; Breathnach R
Biochem Biophys Res Commun; 2005 Oct; 336(2):667-73. PubMed ID: 16137657
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.
Morrison RS; Yamaguchi F; Bruner JM; Tang M; McKeehan W; Berger MS
Cancer Res; 1994 May; 54(10):2794-9. PubMed ID: 8168112
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of the NS2-specific exon in minute virus of mice mRNA is facilitated by an intronic splicing enhancer that affects definition of the downstream small intron.
Haut DD; Pintel DJ
Virology; 1999 May; 258(1):84-94. PubMed ID: 10329570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
